MMP-2 production is decreased following ALK5 inhibition. حسب Rebecca A. Scott (488956)

Methods of assessment of the glottic gap using a rigid endoscope. حسب Ikuo Mikoshiba (9312007)

الموضوعات:

Decreased echinocandin susceptibility in <i>Candida parapsilosis</i> causing candidemia and emergence of a pan-echinocandin resistant case in China حسب Yating Ning (11264310)

BA decreases mitochondrial membrane potential and superoxide production after one day of cell culture. حسب Bandik Föh (602419)

"…<p>(A) Representative contour plots of MT-Green/TMRE-stained B cells after incubation with 0.5 mM BA for 1 day. …"

DataSheet1_WNT5A Interacts With FZD5 and LRP5 to Regulate Proliferation and Self-Renewal of Endometrial Mesenchymal Stem-Like Cells.docx حسب Tianqi Li (1335987)

"…Gene silencing of FZD5 not only reduced the binding of WNT5A to eMSC but also decreased the TCF/LEF transcriptional activities and expression of active β-catenin. …"

DataSheet2_WNT5A Interacts With FZD5 and LRP5 to Regulate Proliferation and Self-Renewal of Endometrial Mesenchymal Stem-Like Cells.docx حسب Tianqi Li (1335987)

"…Gene silencing of FZD5 not only reduced the binding of WNT5A to eMSC but also decreased the TCF/LEF transcriptional activities and expression of active β-catenin. …"

GCase activity is significantly decreased in the brain and liver of the homozygous <i>GBA1</i> D409V KI mouse model at 4, 8, and 12 months of age. حسب Nicole K. Polinski (10947787)

"…In whole brain homogenate (A,C) and liver homogenate (B,D), GCase activity is significantly decreased in the <i>GBA1</i> D409V KI homozygous (HOM) mice as compared to C57Bl/6 wild type (WT) mice (n = 7/group). …"

Sulforaphane decreases IL-6, TNF-α, IL-17, and total IgG levels. حسب Su-Jin Moon (424173)

The G215S mutation decreases packaging of N and growth in primary differentiated human bronchial cells. حسب Hannah C. Kubinski (21213168)

Can inoculation with diazotrophic bacteria decrease the productivity loss of defoliated Vigna unguiculata (L.) Walp? حسب Caliane da S. Braulio (10469226)

Changes in blood pressure before, during and after regadenoson (RA) infusion. حسب Joseph Rabin (7399436)

الموضوعات:

Diagram showing some of the factors that mediate cytokin storm following infection with COVID-19. حسب Joseph Rabin (7399436)

الموضوعات:

Changes of plasma proinflammatory cytokines/chemokines during and after RA infusion. حسب Joseph Rabin (7399436)

الموضوعات:

Demographics of the COVID-19 patients who received regadenoson treatment. حسب Joseph Rabin (7399436)

الموضوعات:

Effects of regadenoson (RA) infusion on oxygen saturation and C-reactive protein (CRP) levels in plasma of COVID-19 patients. حسب Joseph Rabin (7399436)

الموضوعات:

Advancing the science of NOWS research. حسب Sarah E. Maylott (14560785)

"…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"

Protocol measures. حسب Sarah E. Maylott (14560785)

"…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"

Cry variables. حسب Sarah E. Maylott (14560785)

"…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"

Fig 5 - حسب Torsten Schober (20485754)

AIM-100 reduces dsRNA silencing in body wall muscle and decreases DA neurodegeneration. حسب Anthony L. Gaeta (13272609)